FIZE Medical
Patient Monitoring Platform
Company Overview
Snapshot
Founded in April 2020 by Noam Levine, FIZE Medical is a Health Tech & Life Sciences company with 11–50 employees. The company has raised $45.87 million across 7 funding rounds from 6 investors. In July 2026, FIZE Medical received CE mark and UKCA certification for its FIZE kUO System, enabling commercial operations across Europe and the UK.
Business overview
FIZE Medical provides a platform technology for the remote monitoring and management of patients with indwelling Foley catheters. The company develops and manufactures the FIZE kUO device, which offers digital real-time measurement of kidney urine output and key health indicators from urine, providing customized alerts to support evidence-based clinical decision-making. The device, which has been FDA registered and tested in clinical trials, serves the healthcare industry, specifically hospitals, within the Medical Devices and Digital Healthcare sectors.
Strategic signal
In July 2026, FIZE Medical secured CE mark and UKCA certification for its FIZE kUO System, paving the way for commercial operations across Europe and the UK. This regulatory approval is a significant validation of the company's technology and signals a major expansion into key international markets, indicating strong growth potential and broader adoption of its precision fluid management solutions in critical care.
Company Intelligence Q&A
- What significant regulatory approvals did FIZE Medical recently achieve?
- In July 2026, FIZE Medical received CE mark and UKCA certification for its FIZE kUO System, which allows the company to launch commercial operations across Europe and the UK.
- What was the latest funding event for FIZE Medical?
- In March 2026, FIZE Medical announced a $6 million warrant exercise, bringing the total Series A financing to $36 million.
- Did FIZE Medical present at any recent medical conferences?
- In March 2026, FIZE Medical presented a clinical research abstract featuring data from its FIZE kUO platform at the 2026 Society of Critical Care Medicine Congress.
- Which investor led a Series A round for FIZE Medical?
- In January 2025, FIZE Medical secured $30 million in Series A funding, with Rapha Capital Management leading a $14 million Series A-4 round.
- Has FIZE Medical expanded its distribution channels recently?
- In December 2025, FIZE Medical announced an exclusive distribution agreement with Asahi Kasei Medical for the launch of the FIZE kUO System in Japan.